ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619961 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619961; 2) Community: the network communities that were significantly associated with the response to NSC 619961; 3) Molecule: the relationships between components within communities and NSC 619961; 4) MDR: the compounds that were significantly associated with the NSC 619961.

NSC Compound Enrichment Correlation
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.00356914129105574 0.24217801
NSC 754241 6-(2-(dimethylamino)ethoxy)-9-methoxy-11H-indeno[1,2-c]quinolin-11-one 0.00356914129105574 -0.042501936
NSC 756471 SB-732941 0.00356914129105574 0.14363882
NSC 153325 Null 0.00356914129105577 0.046702503
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.00356914129105577 0.44352185
NSC 3053 Actinomycin D 0.00356914129105577 0.13056414
NSC 260594 Benzamide, 4-[(1-methyl-6-nitro-4(1H)-quinolinylidene)amino]-N-[4-[(1-methyl-4(1H)-pyridinylidene)amino]phenyl]- 0.00396220821750022 0.17594882
NSC 5337 Pyridinium, 1-dodecyl-, salt with 5-chloro-2-benzothiazolethiol (1:1) (8CI) 0.00396220821750022 0.31677227
NSC 619042 Cyclohexanone, 2,6-bis[(dimethylamino)methyl]-, dihydrochloride 0.00396220821750022 0.32084964
NSC 639517 Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.00396220821750027 0.35520566
Total:133  Current:21    [First] [Prev] [Next] [Last]